Jacksonville, FL, United States of America

Zbigniew K Wszolek

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Jacksonville, MN (US) (2011)
  • Jacksonville, FL (US) (2009 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zbigniew K Wszolek: Innovator in Parkinsonism Research

Introduction

Zbigniew K Wszolek is a prominent inventor based in Jacksonville, FL (US). He has made significant contributions to the field of medical research, particularly in understanding parkinsonism inheritance. With a total of 3 patents to his name, Wszolek's work is pivotal in advancing genetic research related to Parkinson's disease.

Latest Patents

Wszolek's latest patents include innovative methods and compositions related to LRRK2 polynucleotides. One of his patents describes a polynucleotide consisting of the base sequence of SEQ ID NO:2, or a complementary strand, where the X is defined by the bases A, C, or T. This patent also details a primer and a probe specific for that polynucleotide, which contains at least 10 consecutive nucleotides, and the use of the probe for proving parkinsonism inheritance. Another patent focuses on a method of screening for LRRK2-related parkinsonism inheritance, emphasizing the same polynucleotide characteristics and applications.

Career Highlights

Wszolek is affiliated with the Mayo Foundation for Medical Education and Research, where he conducts his research. His work has been instrumental in the exploration of genetic factors contributing to Parkinson's disease, making him a key figure in this area of study.

Collaborations

Some of Wszolek's notable coworkers include Jan O Aasly and Matthew J Farrer. Their collaborative efforts contribute to the ongoing research and development in the field of parkinsonism.

Conclusion

Zbigniew K Wszolek's innovative research and patents play a crucial role in understanding and addressing parkinsonism inheritance. His contributions continue to impact the medical community and advance the field of genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…